Related Experiment Video
Updated: Oct 10, 2025

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL
Antonin Bouroumeau1,2,3, Lucile Bussot2,4, Sieme Hamaidia2,5
1Department of Pathology, Grenoble-Alpes University Hospital, 38000 Grenoble, France.
New research identifies CYCLON and NPM1 proteins as key predictors of treatment resistance in diffuse large B-cell lymphoma (DLBCL). Their specific locations within cells indicate a higher risk of refractory disease, guiding future therapies.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Diffuse large B-cell lymphoma (DLBCL) treatment with R-CHOP immunotherapy has improved outcomes, yet a significant portion of patients experience refractory disease or relapse.
- Current prognostic markers often fail to accurately stratify high-risk DLBCL patients.
- Previous studies linked the nuclear protein CYCLON to DLBCL progression and immunotherapy resistance.
Purpose of the Study:
- To elucidate the biological role and interaction network of CYCLON in DLBCL.
- To investigate the potential role of NPM1, a nucleolar protein, in DLBCL treatment resistance.
- To evaluate CYCLON and NPM1 as prognostic markers for DLBCL, particularly in relation to R-CHOP therapy.
Main Methods:
- Characterization of the CYCLON protein interaction network.
- Analysis of CYCLON's connection to nucleolus, RNA processing, MYC signaling, and cell cycle.
- Immunohistochemistry evaluation of CYCLON and NPM1 expression and sub-cellular localization in DLBCL patient cohorts.
Main Results:
- CYCLON interacts with proteins involved in RNA processing, MYC signaling, and cell cycle progression.
- NPM1 emerged as a potential target linked to treatment resistance in DLBCL.
- Co-expression of CYCLON and NPM1 strongly correlates with inferior prognosis in DLBCL patients.
- Alternative sub-cellular localizations (extra-nucleolar CYCLON, pan-cellular NPM1) are independent predictors of R-CHOP refractory DLBCL.
Conclusions:
- CYCLON and NPM1 play a significant role in DLBCL pathogenesis and treatment resistance.
- Their specific sub-cellular localization patterns can predict refractory disease in DLBCL patients treated with R-CHOP.
- These findings may guide risk-adapted treatment strategies and the development of novel targeted therapies for high-risk DLBCL.
More Related Videos
10:54Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Positive Regulator Molecules
Anaphase Promoting Complex
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
Inhibition of Cdk Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...